Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 84950 · Class II · OneBlood, Inc.
Key facts
| Event ID | 84950 |
|---|---|
| Recall numbers | B-0333-2020 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed. |
| Initiation date | Jan 30, 2020 |
| Report date | Feb 26, 2020 |
| Termination date | Feb 18, 2020 |
| City | Orlando |
| State | FL |
| Country | United States |
| FEI number | 1072425 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: